Astro-Med, Inc.'s Grass Technologies Donates Ambulatory EEG System for Auction in Support of American Epilepsy Society Research Funds


WEST WARWICK, RI, Jul 19, 2010 (MARKETWIRE via COMTEX) -- Astro-Med, Inc. (NASDAQ: ALOT) and Grass Technologies today announced that they will auction a complete ambulatory EEG Recorder System to support the American Epilepsy Society's Lennox and Lombroso Trust and Susan S. Spencer Funds for Epilepsy Research and Training. The online auction has already commenced, and is being held at: One hundred percent of the auction proceeds will be donated to the American Epilepsy Society and will be presented to the AES during the annual AES meeting held in San Antonio, TX.

The recently introduced unit, called the TREA ambulatory EEG system, is the latest amplifier system from Grass Technologies for patients to wear at home to record their EEG for one or more days. With 27 channels, it has the capability of recording data for 72 hours. The TREA is said to be the smallest and most compact ambulatory EEG recorder of its type in the industry. It is expected that the auction will yield near the full value of the $15,000 system.

"Since support for epilepsy research has declined in recent years, the donation of the proceeds of an auction for an ambulatory EEG system by Grass Technologies is a welcome contribution. We are engaged in an effort to create a secure foundation for epilepsy education and research by bolstering research support from within, and we have chosen the Lennox and Lombroso Trust and the new Susan S. Spencer Fund as key entities to support research and training," said Suzanne C. Berry, MBA, CAE, Executive Director of the American Epilepsy Society.

"I hope many will bid on our TREA EEG system, and I encourage all to contribute to The Lennox and Lombroso Trust and Susan S. Spencer Funds which support early career grants and clinical research fellowships for some of the brightest minds in the epilepsy community," said Everett V. Pizzuti, President and COO of Astro-Med, Inc. and Grass Technologies.

He continued, "Astro-Med, Inc. and Grass Technologies are committed to advancing the study of epilepsy, and to the development of diagnoses and treatments for this disorder that affects 50 million people worldwide."

About American Epilepsy Society (AES); Lennox and Lombroso Trust; and the Susan S. Spencer Fund

The AES is the world's premiere society for professional training in epilepsy treatment and research. With an ongoing commitment to education and research, it has earmarked a significant portion of its operating income for educational support. To learn more about the AES, visit For more information about the Lennox and Lombroso Trust and the Susan S. Spencer Fund, visit

About Grass Technologies

Grass(R) Technologies, an Astro-Med, Inc. Product Group, is a world leader in neurophysiological monitoring instruments and software designed to detect, amplify, and display the electrical activity of the brain. Primary applications of Grass products include Sleep Monitoring and Analysis, Long-Term Monitoring (LTM), EEG Monitoring, and Neurophysiological Research Studies. Customers include sleep centers and clinics, hospitals, universities, and pharmaceutical companies. More information about the TREA ambulatory EEG System and Grass Technologies is available at:, or by telephoning 877-472-7779 toll-free in the USA and Canada.

About Astro-Med, Inc.

Astro-Med, Inc. is a leading manufacturer of specialty high tech printing systems, electronic medical instrumentation, and test and measurement instruments. Astro-Med, Inc. products are sold under the brand names Astro-Med(R), Grass Technologies, and QuickLabel(R) Systems, and are employed around the world in a wide range of aerospace, medical, military, industrial, and packaging applications. Astro-Med, Inc. is a member of the Russell Microcap(R) Index. Additional information is available by visiting

Safe Harbor Statement

This news release contains forward-looking statements, and actual results may vary from those expressed or implied herein. Factors that could affect these results include those mentioned in Astro-Med's FY2010 annual report and its annual and quarterly filings with the Securities and Exchange Commission.

Everett V. Pizzuti
President & COO
Astro-Med, Inc.

SOURCE: Astro-Med, Inc.

View all news

IR Contact

AstroNova, Inc.
Investor Relations Department
600 East Greenwich Avenue
West Warwick, RI 02893
Scott Solomon
Senior Vice President Sharon Merrill
Phone: (617) 542-5300

Email Alerts

Email Address *

Enter the code shown above.

Interactive Analyst Center Disclaimer

The financial data and other material provided to users in the pages of the website is for information purposes only. Users should not rely on information on this website for any purpose other than for obtaining general knowledge of AstroNova. Material may be changed or updated without notice.

AstroNova, Inc.